Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma

por Affronti, Mary Lou, Jackman, Jennifer Gamboa, McSherry, Frances, Herndon, James E., Massey, Elwood C., Lipp, Eric, Desjardins, Annick, Friedman, Henry S., Vlahovic, Gordana, Vredenburgh, James, Peters, Katherine B.
Publicado 2018

Design of the Healthcare Worker Exposure Response and Outcomes (HERO) research platform

por Friedland, Anne, Hernandez, Adrian F., Anstrom, Kevin J., Chen-Lim, Mei Lin, Cohen, Lauren W., Currier, Judith S., Forrest, Christopher B., Fraser, Ryan, Fraulo, Elizabeth, George, Anoop, Handberg, Eileen, Jackman, Jennifer, Koellhoffer, Jayne, Lawrence, Daryl, Leverty, Renee, McAdams, Patty, McCourt, Brian, Mickley, Brenda, Naqvi, Syed Hasan, O'Brien, Emily C., Olson, Rachel, Prater, Clyde, Rothman, Russell L., Shenkman, Elizabeth, Shostak, Jack, Turner, Kisha Batey, Webb, Laura, Woods, Chris, Naggie, Susanna
Publicado 2021